Tag: Stroke risk

In clinical trials for the Alzheimer's medication LEQEMBI (lecanemab), up to 12.6% of patients experienced brain swelling (ARIA-E) and 17.3% experienced brain bleeding (ARIA-H), which was higher than in the placebo group. While often asymptomatic, these side effects can, in rare cases, manifest with serious, stroke-like symptoms or lead to fatal brain hemorrhages, raising concerns about if **LEQEMBI can cause a stroke**. The U.S. Food and Drug Administration (FDA) has issued a black box warning to highlight this significant safety risk.

It is estimated that around 20% of women using hormonal contraception discontinue its use due to side effects like headaches. Understanding the complex relationship between fluctuating hormone levels from birth control and headache patterns is crucial, especially when deciding, 'Should I stop taking the pill if I have headaches?'.

In November 2000, the U.S. Food and Drug Administration (FDA) issued a public health advisory and requested that all drug companies discontinue marketing products containing phenylpropanolamine (PPA). So, regarding how many times a day can you take phenylpropanolamine, the answer is zero.

While many factors contribute to stroke, understanding **what medications increase the risk of stroke** is a vital step in proactive healthcare and stroke prevention. This awareness allows for informed discussions with healthcare providers regarding the balance of treatment benefits and risks.

In 2000, the U.S. Food and Drug Administration (FDA) issued a public health warning and subsequently requested that manufacturers stop marketing products containing phenylpropanolamine (PPA), effectively banning its sale due to a link to an increased risk of hemorrhagic stroke. Therefore, the answer to the question, 'Can I take phenylpropanolamine and cetirizine together?', is a definitive **no**, due to the serious safety risks associated with PPA. This guide explains why this combination is dangerous and outlines the safer, modern alternatives for treating cold and allergy symptoms.

In 2023, losartan-hydrochlorothiazide was one of the most commonly prescribed medications in the United States, with over 9 million prescriptions. So, what does losartan H treat? This combination medication is primarily used to manage high blood pressure (hypertension) and prevent serious cardiovascular events.

In the year 2000, the U.S. Food and Drug Administration (FDA) issued a public health advisory concerning the popular decongestant ingredient phenylpropanolamine (PPA), which led to the banning of many over-the-counter products, including certain formulations of Drixoral. This decision was based on new scientific evidence linking PPA to an increased risk of hemorrhagic stroke, a severe and potentially life-threatening side effect.

Between 200 and 500 strokes per year among users aged 18 to 49 were estimated to be caused by products containing phenylpropanolamine (norephedrine), leading to its withdrawal from the market around 2000. This substance, also known as PPA, had a complex history of use, but its association with severe health risks has since redefined what is norephedrine used for in modern medicine.

According to a 2021 review, a limited number of drugs have a high level of association with ischemic stroke. This article explores what drugs cause strokes, both illicit and prescribed, and the mechanisms behind these risks.

According to the FDA, discontinuing Eliquis without adequate continuous anticoagulation significantly increases the risk of stroke, a warning highlighted in the medication's official prescribing information. The question, **can stopping Eliquis cause a stroke?**, is a critical concern for patients considering a change in their medication regimen.